# Continental Services Group, Inc. – FDA 483, Jun 29, 2026

Source: https://www.keypedia.com/records/483/continental-services-group-inc/442913d3-156d-49ec-8c82-8b8463a89519

> FDA 483 for Continental Services Group, Inc. on June 29, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Continental Services Group, Inc.
- Inspection Date: 2026-06-29
- Product Type: biologics
- Office Name: Florida District Office
- Summary: Continental Services Group, Inc. in Miami, FL, a blood bank establishment, was cited for three significant observations during an FDA inspection. The firm failed to properly investigate severe adverse donor reactions and conduct required follow-ups. Additionally, deficiencies were noted in the quality control and calibration of centrifuges used for blood processing, and in maintaining complete records identifying personnel and dates for work performed, specifically for source plasma donor records.

## Related Documents

- [483 - 2019-07-09](https://www.keypedia.com/records/483/continental-services-group-inc/0cf3e35c-a346-4edd-a397-675618242d39) — date: July 9, 2019

## Related Officers

- [Nerming V. Briones](https://www.keypedia.com/people/nerming-v-briones/b2d9e685-a627-4f9e-854c-0588865fd1b6)
- [Annette Melendez](https://www.keypedia.com/people/annette-melendez/bc1a065d-6408-4c4b-9dcf-c6884e8a75c4)

Company: https://www.keypedia.com/companies/continental-services-group-inc/6a7a7180-4020-4fc8-a2f2-ca4ab032c3a4

Office: https://www.keypedia.com/offices/florida-district-office/95b2a118-0b78-46e0-a54c-982bd7ce51c9